Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application

Publication date

2021-11

Authors

Rousou, CharisISNI 0000000492918475
Schuurmans, Carl C.L.ISNI 0000000493311341
Urtti, Arto
Mastrobattista, E.ORCID 0000-0002-6745-2015ISNI 000000035187179X
Storm, GertISNI 0000000042534976
Moonen, Chrit
Kaarniranta, Kai
Deckers, RoelISNI 0000000357092076

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

The unique anatomy of the eye and the presence of various biological barriers make efficacious ocular drug delivery challenging, particularly in the treatment of posterior eye diseases. This review focuses on the combination of ultrasound and microbubbles (USMB) as a minimally invasive method to improve the efficacy and targeting of ocular drug delivery. An extensive overview is given of the in vitro and in vivo studies investigating the mechanical effects of ultrasound-driven microbubbles aiming to: (i) temporarily disrupt the blood-retina barrier in order to enhance the delivery of systemically administered drugs into the eye, (ii) induce intracellular uptake of anticancer drugs and macromolecules and (iii) achieve targeted delivery of genes, for the treatment of ocular malignancies and degenerative diseases. Finally, the safety and tolerability aspects of USMB, essential for the translation of USMB to the clinic, are discussed.

Keywords

ultrasound, microbubble, drug delivery, blood–retina barrier, ocular drug delivery, USMB, cellular drug delivery

Citation

Rousou, C, Schuurmans, C C L, Urtti, A, Mastrobattista, E, Storm, G, Moonen, C, Kaarniranta, K & Deckers, R 2021, 'Ultrasound and Microbubbles for the Treatment of Ocular Diseases : From Preclinical Research towards Clinical Application', Pharmaceutics, vol. 13, no. 11, 1782, pp. 1-35. https://doi.org/10.3390/pharmaceutics13111782